https://www.selleckchem.com/products/GDC-0449.html
A single-arm prospective study was conducted among Japanese patients with type 2 diabetes having preserved ejection fraction. The aim was to investigate (1) whether liraglutide therapy could improve B-type natriuretic peptide (BNP) levels and diastolic cardiac function assessed by the -wave to ' ratio ( / ' using transthoracic echocardiography (TTE), and (2) whether / ' contributed to BNP improvement independent of bodyweight reduction (UMIN000005565). Patients with type 2 diabetes and left ventricular ejection fraction (LVEF) ≥ 40% w
Like
Comment
Share
